Form 10-Q
 



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
(Mark One)

ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2006

or

¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission file number: 001-32209

WELLCARE HEALTH PLANS, INC.
(Exact name of registrant as specified in its charter)

Delaware
47-0937650
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)

8725 Henderson Road, Renaissance One
Tampa, Florida
 
33634
(Address of principal executive offices)
(Zip Code)

(813) 290-6200
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ý No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer.  See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

.
Large Accelerated Filer o Accelerated Filer  ý Non-Accelerated Filer o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o No ý

As of August 2, 2006, there were 40,613,012 shares of the registrant’s common stock, par value $.01 per share, outstanding.
 



 
 
 TABLE OF CONTENTS
 
 
 
Page
 
   
 
1
2
3
4
   
11
   
22
   
22
   
 
   
24
   
24
   
24
   
24
   
25
   
26

 
 
Item 1:  Financial Statements.
 
WELLCARE HEALTH PLANS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, in thousands, except share data)

   
June 30,
 
December 31,
 
 
 
2006
 
2005
 
Assets
         
Current Assets:
         
Cash and cash equivalents
 
$
834,159
 
$
421,766
 
Investments
   
178,842
   
94,160
 
Premium receivables, net
   
85,058
   
47,567
 
Other receivables from government partners
   
118,489
   
-
 
Income taxes receivable
   
-
   
11,575
 
Deferred income taxes
   
27,355
   
11,353
 
Prepaids and other current assets
   
49,076
   
19,036
 
Total current assets
   
1,292,979
   
605,457
 
Property and equipment, net
   
53,545
   
37,057
 
Goodwill
   
185,779
   
185,779
 
Other intangibles, net
   
20,321
   
21,668
 
Restricted investment assets
   
48,503
   
37,308
 
Other assets
   
2,209
   
220
 
Total Assets
 
$
1,603,336
 
$
887,489
 
Liabilities and Stockholders' Equity
             
Current Liabilities:
             
Medical benefits payable
 
$
422,054
 
$
241,375
 
Unearned premiums
   
161,921
   
12,606
 
Accounts payable
   
56,758
   
4,867
 
Other accrued expenses
   
70,628
   
52,976
 
Deferred income taxes
   
1,191
   
1,260
 
Taxes payable
   
12,128
   
-
 
Note payable to related party
   
25,000
   
25,000
 
Current portion of long-term debt
   
1,600
   
1,600
 
Funds held for the benefit of members
   
224,730
   
-
 
Other current liabilities
   
410
   
358
 
Total current liabilities
   
976,420
   
340,042
 
Long-term debt
   
154,741
   
155,461
 
Deferred income taxes
   
18,262
   
16,577
 
Other liabilities
   
7,428
   
5,285
 
Commitments and contingencies (see Note 3)
   
-
   
-
 
Total liabilities
   
1,156,851
   
517,365
 
Stockholders' Equity:
             
Preferred stock, $0.01 par value (20,000,000 authorized, no shares issued or outstanding)
   
-
   
-
 
Common stock, $0.01 par value (100,000,000 authorized, 40,565,938 and 39,428,032 shares
             
issued and outstanding at June 30, 2006 and December 31, 2005, respectively)
   
406
   
394
 
Paid-in capital
   
277,764
   
240,337
 
Retained earnings
   
168,315
   
129,372
 
Accumulated other comprehensive income
   
-
   
21
 
Total stockholders' equity
   
446,485
   
370,124
 
Total Liabilities and Stockholders' Equity
 
$
1,603,336
 
$
887,489
 
 
             
 
See notes to condensed consolidated financial statements.
 
WELLCARE HEALTH PLANS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited, in thousands, except share data)
 


 
 
Three Months
 
Six Months
 
 
 
Ended June 30,
 
Ended June 30,
 
 
 
2006
 
2005
 
2006
 
2005
 
Revenues:
                 
Premium
 
$
842,658
 
$
450,188
 
$
1,564,878
 
$
866,054
 
Investment and other income
   
10,153
   
3,488
   
18,317
   
6,503
 
Total revenues
   
852,811
   
453,676
   
1,583,195
   
872,557
 
Expenses:
                         
Medical benefits
   
704,964
   
365,804
   
1,304,047
   
710,730
 
Selling, general and administrative
   
104,566
   
59,093
   
201,831
   
110,341
 
Depreciation and amortization
   
3,254
   
2,048
   
6,344
   
4,090
 
Interest
   
3,674
   
3,566
   
7,058
   
6,771
 
Total expenses
   
816,458
   
430,511
   
1,519,280
   
831,932
 
Income before income taxes
   
36,353
   
23,165
   
63,915
   
40,625
 
Income tax expense
   
14,179
   
9,011
   
24,973
   
15,831
 
Net income
 
$
22,174
 
$
14,154
 
$
38,942
 
$
24,794
 
                           
Net income per common share (see Note 1):
                         
Net income per common share — basic
 
$
0.56
 
$
0.38
 
$
1.00
 
$
0.66
 
Net income per common share — diluted
 
$
0.55
 
$
0.36
 
$
0.97
 
$
0.64
 
 
See notes to condensed consolidated financial statements.
 
 

 
WELLCARE HEALTH PLANS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
 
 
 
Six Months
 
 
 
Ended June 30,
 
 
 
2006
 
2005
 
Cash from operating activities:
         
Net income
 
$
38,942
 
$
24,794
 
Adjustments to reconcile net income to net cash provided by
operating activities:
             
Depreciation and amortization expense
   
6,344
   
4,090
 
Realized (unrealized) gain on investments
   
(21
)
 
18
 
Loss on disposal of fixed assets
   
1,259
   
-
 
Equity-based compensation expense, net of tax benefits
   
12,575
   
1,171
 
Incremental tax benefit received for option exercises
   
(2,160
)
 
-
 
Deferred taxes, net
   
(14,386
)
 
6,465
 
Changes in operating accounts:
           
Premiums receivable
   
(37,491
)
 
(12,071
)
Other receivables from government partners
   
(118,489
)
     
Prepaid expenses and other, net
   
(29,753
)
 
2,111
 
Medical benefits payable
   
180,679
   
21,732
 
Unearned premiums
   
149,315
   
(63,216
)
Accounts payable and accrued expenses
   
69,266
   
3,438
 
Taxes payable, net
   
23,703
   
(9,302
)
Net cash provided by (used in) operating activities
   
279,783
   
(20,770
)
Cash from investing activities:
             
Proceeds from sale and maturities of investments
   
49,371
   
25,719
 
Purchases of investments
   
(134,053
)
 
(128,294
)
Purchases and dispositions of restricted investments, net
   
(11,195
)
 
(4,332
)
Additions to property and equipment, net
   
(21,523
)
 
(11,496
)
Other investing activities
   
(944
)
 
(4,931
)
Net cash used in investing activities
   
(118,344
)
 
(123,334
)
Cash from financing activities:
             
Proceeds from common stock issuance, net
   
21,550
   
-
 
Proceeds from option exercises and other
   
3,302
   
772
 
Common stock
   
12
   
-
 
Incremental tax benefit received for option exercises
   
2,160
   
-
 
Repayments on debt
   
(800
)
 
(800
)
Funds received for the benefit of members, net of disbursements
   
224,730
   
-
 
Net cash provided by (used in) financing activities
   
250,954
   
(28
)
Cash and cash equivalents:
             
Increase (decrease) during period
   
412,393
   
(144,132
)
Balance at beginning of period
   
421,766
   
397,627
 
Balance at end of period
 
$
834,159
 
$
253,495
 
               
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION —
             
Cash paid for taxes
 
$
13,883
 
$
18,671
 
Cash paid for interest
 
$
6,810
 
$
6,841
 
Non-cash property and equipment additions
 
$
(278
)
$
-
 

See notes to condensed consolidated financial statements
 
3

WELLCARE HEALTH PLANS, INC.
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
(Unaudited, in thousands, except member and share data)
 
 
1.
ORGANIZATION AND BASIS OF PRESENTATION

WellCare Health Plans, Inc., a Delaware corporation (the “Company”), provides managed care services targeted exclusively to government-sponsored healthcare programs, focusing on Medicaid and Medicare. Through its health plans, the Company operates a variety of Medicaid and Medicare plans, including health plans for families, children, the aged, blind and disabled, and prescription drug plans, serving in aggregate approximately 2,011,000 members as of June 30, 2006. Through its licensed subsidiaries, as of June 30, 2006 the Company operates its Medicaid health plans in Florida, New York, Connecticut, Illinois, Indiana and Georgia and its Medicare Advantage health plans in Florida, New York, Connecticut, Illinois, Louisiana and Georgia. Additionally, beginning in January 2006, the Company began operations as a stand-alone Medicare prescription drug plan (“PDP”) in all 50 states and the District of Columbia.

Basis of Presentation

The accompanying unaudited condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December 31, 2005 included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2005 (“2005 Form 10-K”), filed with the Securities and Exchange Commission (the “SEC”) in February 2006, as amended. In the opinion of the Company's management, the interim financial statements reflect all normal recurring adjustments which the Company considers necessary for the fair presentation of the financial position and results of operations and cash flows for the interim periods presented. The interim financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. Results for the interim periods presented are not necessarily indicative of results that may be expected for the entire year or any other interim period.

Funds held for the benefit of members represent government payments received to subsidize the member portion of medical payments for certain of our PDP members. These funds are not included in the Company’s results of operations since such funds represent pass-through payments from our government partners to fund deductibles, co-payments and other member benefits for certain of our members.

Certain 2005 amounts in the condensed consolidated interim financials statements have been reclassified to conform to the 2006 presentation. These reclassifications have no effect on net income, total current and long-term assets, liabilities or stockholders’ equity as previously reported.

Public Offerings

In March 2006, the Company completed a public offering of common stock whereby 500,000 shares were sold by the Company and 4,350,000 shares were sold by selling stockholders. The Company received net proceeds of approximately $18,800 from this offering. Subsequently, in April 2006, the over-allotment option of 727,500 shares was fully exercised, of which 75,000 were sold by the Company and 652,500 were sold by selling stockholders. The Company received net proceeds of approximately $2,800 from this over-allotment transaction. The Company did not receive any proceeds from the sale of shares of common stock by the selling stockholders in either transaction.

Net Income Per Common Share

The Company computes basic net income per common share on the basis of the weighted average number of unrestricted common shares outstanding. Diluted net income per common share is computed on the basis of the weighted average number of unrestricted common shares outstanding plus the dilutive effect of outstanding restricted shares and employee stock options using the treasury stock method.

4

WELLCARE HEALTH PLANS, INC.
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
 
(Unaudited, in thousands, except member and share data)

 
The following table presents the calculation of net income per common share - basic and diluted:

   
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
   
(Unaudited)
 
(Unaudited)
 
   
2006
 
2005
 
2006
 
2005
 
                   
Numerator:
                 
Net income - basic and diluted
 
$
22,174
 
$
14,154
 
$
38,942
 
$
24,794
 
Denominator:
                         
Weighted average common shares outstanding - basic
   
39,345,011
   
37,573,264
   
38,970,062
   
37,412,929
 
Dilutive effect of:
                         
unvested restricted common shares
   
523,931
   
486,272
   
560,039
   
646,523
 
stock options
   
761,512
   
797,291
   
766,383
   
814,668
 
Weighted average common shares outstanding - diluted
   
40,630,454
   
38,856,827
   
40,296,484
   
38,874,120
 
                           
Net income per common share:
                         
Net income per common share - basic
 
$
0.56
 
$
0.38
 
$
1.00
 
$
0.66
 
Net income per common share - diluted
 
$
0.55
 
$
0.36
 
$
0.97
 
$
0.64
 


Certain options to purchase common stock were not included in the calculation of diluted net income per common share because their exercise prices were greater than the average market price of the Company’s common stock for the period and, therefore, the effect would be anti-dilutive. For the three-month and six-month periods ended June 30, 2006, approximately 79,000 shares with exercise prices ranging from $47.40 to $48.50 per share were excluded from diluted weighted average common shares outstanding.

Recently Issued Accounting Standards

In May 2005, Statement of Financial Accounting Standard (“SFAS”) No. 154, “Accounting Changes and Error Corrections” - replacement of Accounting Principals Board (“APB”) Opinion No. 20 and Financial Accounting Standards Board (“FASB”) Statement No. 3, (“SFAS No. 154”) was issued. SFAS No. 154 changes the accounting for and reporting of a change in accounting principle by requiring retrospective applications to prior periods’ financial statements, unless impracticable. The Company adopted SFAS No. 154 effective January 1, 2006. The adoption had no impact on the Company.

In December 2004, the FASB issued Statement No. 123(R) (“SFAS No. 123(R)”), “Share-Based Payment,” that requires compensation costs related to share-based payment transactions to be recognized in the financial statements. The Company is required to comply with SFAS No. 123(R) for the three-month and six-month periods ended June 30, 2006. In March 2005, the SEC issued Staff Accounting Bulletin No. 107, Share-Based Payment, which provides interpretive guidance related to the interaction between SFAS No. 123(R) and certain SEC rules and regulations, as well as provides the SEC staff’s views regarding the valuation of share-based payment arrangements. See Note 4 regarding the impact of these pronouncements on the Company’s financial statements.

5

WELLCARE HEALTH PLANS, INC.
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
 
(Unaudited, in thousands, except member and share data)

2. SEGMENT REPORTING

The Company has two reportable segments: Medicaid and Medicare. The segments were determined based upon the type of governmental administration, regulation and funding of the health plans. Segment performance is evaluated based upon earnings from operations without corporate allocations. Accounting policies of the segments are consistent with those applied at December 31, 2005.

The Medicaid segment includes operations which provide healthcare services to recipients that are eligible for state supported programs including Medicaid and family and children's health programs. The Medicare segment includes operations which provide health and prescription drug plan services to recipients who are eligible for the federally supported Medicare program.

Asset, liability and equity amounts by segment have not been disclosed, as they are not reported by segment internally by the Company.


   
Three Months
Ended June 30,
 
Six Months
Ended June 30,
 
   
(Unaudited)
 
(Unaudited)
 
   
2006
 
2005
 
2006
 
2005
 
Premium revenue:
                 
Medicaid
 
$
387,950
 
$
330,533
 
$
741,425
 
$
639,743
 
Medicare
   
454,708
   
119,655
   
823,453
   
226,311
 
Total
   
842,658
   
450,188
   
1,564,878
   
866,054
 
Medical benefits expense:
                         
Medicaid
   
310,258
   
269,500
   
589,450
   
527,496
 
Medicare
   
394,706
   
96,304
   
714,597
   
183,234
 
Total
   
704,964
   
365,804
   
1,304,047
   
710,730
 
Gross margin:
                         
Medicaid
   
77,692
   
61,033
   
151,975
   
112,247
 
Medicare
   
60,002
   
23,351
   
108,856
   
43,077
 
Total
 
$
137,694
 
$
84,384
 
$
260,831
 
$
155,324
 


3. COMMITMENTS AND CONTINGENCIES

The Company is involved in legal actions in the normal course of business, some of which seek monetary damages, including claims for punitive damages, which, if payable, would not be covered by insurance. These actions, when finally concluded and determined, will not in the opinion of management have a material adverse effect on the Company’s financial position, results of operations or cash flows. The Company believes that it has obtained adequate insurance or rights to indemnification or, where appropriate, has established adequate reserves in connection with these legal proceedings.


4. EQUITY-BASED COMPENSATION

The Company currently has four equity-based compensation plans. Effective January 1, 2006, the Company adopted the provisions of SFAS No. 123(R) for its equity-based compensation plans. The Company previously accounted for these plans under the recognition and measurement principles of APB Opinion No. 25,  Accounting for Stock Issued to Employees” (“APB25”).

6

WELLCARE HEALTH PLANS, INC.
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
 
(Unaudited, in thousands, except member and share data)


Under APB25, compensation cost for stock options was reflected in net income and was measured as the excess of the market price of the Company’s stock at the date of the grant over the amount an employee had to pay to acquire the stock. The Company utilized the intrinsic-value method for measurement of compensation awards as specified in APB25. Under SFAS No. 123(R), all share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as an expense in earnings over the requisite service period.

The Company adopted SFAS No. 123(R) effective January 1, 2006, using the modified-prospective transition method. Under this method, compensation cost is recognized for awards granted and for awards modified, repurchased or cancelled in the period after adoption. Compensation cost is also recognized for the unvested portion of awards granted prior to adoption. This cost was based on the grant-date fair value estimated in accordance with the original provisions of SFAS No. 123, Accounting for Stock-Based Compensation (“SFAS 123”). The cost for all equity-based compensation awards granted subsequent to December 31, 2005 represents the grant-date fair value that was estimated in accordance with the provisions of SFAS No. 123(R). Results for prior periods have not been restated.

The Company will continue to use the Black-Scholes model for valuing the shares granted under equity-based compensation plans. Compensation cost for all awards will be recognized in earnings, net of estimated forfeitures, on a straight-line basis for new or modified awards after January 1, 2006 and an accelerated method for existing awards, over the requisite service period.

The table below illustrates the effect on net income and earnings per share as if the Company had applied the fair-value recognition provisions of SFAS No. 123 to all of its equity-based compensation awards for all periods presented. For purposes of this pro forma disclosure, the value of the equity-based compensation awards is estimated using a Black-Scholes option-pricing model and amortized to expense over the awards’ vesting period using an accelerated expensing method.

 
   
Three Months Ended
June 30, 2005
 
Six Months Ended
June 30, 2005
 
   
(Unaudited)
 
(Unaudited)
 
           
Net income, as reported
 
$
14,154
 
$
24,794
 
               
Total stock-based employee compensation expense included in the determination of reported net income, net of related tax effect of $183 and $463, respectively
   
286
   
724
 
Total stock-based compensation expense determined under fair value based method for all awards, net of related tax effects of $1,268 and $2,614, respectively
   
(1,983
)
 
(4,088
)
Pro forma net income for calculation of basic and diluted earnings per share
 
$
12,457
 
$
21,430
 
               
Net income per common share:
             
Basic-as reported
 
$
0.38
 
$
0.66
 
Basic-pro forma
 
$
0.33
 
$
0.57
 
Diluted-as reported
 
$
0.36
 
$
0.64
 
Diluted-pro forma
 
$
0.32
 
$
0.55
 

 
WELLCARE HEALTH PLANS, INC.
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
 
(Unaudited, in thousands, except member and share data)

Cash received from option exercises under all share-based payment arrangements for the three months ended June 30, 2006 and 2005 was $1,595 and $210, respectively; and $3,302 and $784 for the six months ended June 30, 2006 and 2005, respectively. The Company currently expects to satisfy equity-based compensation awards with registered shares available to be issued.

Equity compensation plans

As of June 30, 2006, the Company had four equity-based compensation plans, which are described below. The compensation cost that has been charged against income for those plans was $4,671 and $469 for the three months ended June 30, 2006 and 2005, respectively; and $8,650 and $1,187 for the six months ended June 30, 2006 and 2005, respectively. The total income tax benefit recognized in the income statement for equity-based compensation arrangements was $1,134 and $183 for the three months ended June 30, 2006 and 2005, respectively; and $3,925 and $463 for the six months ended June 30, 2006 and 2005, respectively. The tax benefit realized by the Company reflects the exercise value of options and vesting of restricted shares. There were no capitalized equity-based compensation costs at June 30, 2006.

In September 2002, the Company’s board of directors adopted two equity plans, the 2002 Senior Executive Equity Plan and the 2002 Employee Option Plan. Both plans permit senior executives and other key associates selected to participate to acquire ownership interests in the Company. The Company does not currently intend to issue any additional awards under either of these plans.

In June 2004, the Company’s board of directors adopted, and its shareholders subsequently approved, the Company’s 2004 Equity Incentive Plan. An aggregate of 4,688,532 shares of the Company’s common stock was initially reserved for issuance to the Company’s directors, associates and others under this plan. The number of shares reserved for issuance is subject to an annual increase effective on January 1 of each year, commencing on January 1, 2005 and ending on January 1, 2013. Effective January 1, 2006, 1,182,840 additional shares were reserved for issuance under the plan. Option awards are generally granted with an exercise price equal to the closing market price of the Company’s stock on the date of grant; those option awards generally vest based on five years of continuous service and have seven-year contractual terms. Share awards generally vest over five years.

The fair value of each option award is estimated on the date of grant using a Black-Scholes option pricing model that uses the assumptions noted in the table below. Expected volatilities are based on historical volatility of the Company’s stock and other companies with similar trading longevity and operating similar businesses. The expected term of options granted is determined using historical and industry data to estimate option exercise patterns and forfeitures resulting from employee terminations. The Company has not historically declared dividends, nor does it intend to in the foreseeable future. The risk-free rate for options granted is based on the rate for zero-coupon U.S. Treasury bonds with terms commensurate with the expected term of the granted option.

 

   
Three Months Ended
June 30
 
Six Months Ended
June 30
 
 
 (Unaudited)
 
 (Unaudited)
   
2006
 
2005
 
2006
 
2005
Weighted average risk-free interest rate
 
5.00%
 
3.76%
 
4.74%
 
3.83%
Range of risk-free rates
 
4.89%-5.10%
 
3.73%-4.17%
 
4.28%-5.10%
 
3.67%-4.30%
Expected term (in years)
 
2.7
 
4.5
 
3.6
 
4.8
Expected dividend yield
 
0%
 
0%
 
0%
 
0%
Expected volatility
 
42.0%
 
46.4%
 
42.0%
 
46.4%

8

WELLCARE HEALTH PLANS, INC.
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
 
(Unaudited, in thousands, except member and share data)

The following table summarizes option activity from January 1, 2006 through June 30, 2006:

   
 
Shares
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Life (Years)
 
 
Aggregate Intrinsic Value
 
   
 (Unaudited) 
 
 (Unaudited) 
 
                   
Outstanding at January 1, 2006
   
2,834,196
 
$
21.32
             
Options granted
   
288,100
   
42.56
             
Options exercised
   
(273,297
)
 
13.81
             
Options cancelled
   
(192,696
)
 
25.64
             
Outstanding at June 30, 2006
   
2,656,303
   
24.08
   
7.2
 
$
66,328
 
Exercisable at June 30, 2006
   
809,983
 
$
15.70
   
7.4
 
$
27,016
 


The weighted-average grant date fair value of options granted during the three months ended June 30, 2006 and 2005 was $14.62 and $14.87, respectively; and $15.41 and $14.63 for the six months ended June 30, 2006 and 2005, respectively. The total intrinsic value of options exercised during the three months ended June 30, 2006 and 2005 was $4,151 and $1,331, respectively; and $8,265 and $3,646 for the six months ended June 30, 2006 and 2005, respectively.


The following table summarizes restricted share activity from January 1, 2006 through June 30, 2006:

   
Shares
 
Weighted-Average Grant-Date Fair Value
 
   
(Unaudited)
 
           
Nonvested balance at January 1, 2006
   
1,070,308
 
$
16.36
 
Changes during the period:
             
Shares granted
   
314,594
   
41.79
 
Shares vested
   
(310,480
)
 
5.71
 
Shares forfeited
   
(26,643
)
 
16.44
 
Nonvested balance at June 30, 2006
   
1,047,779
   
27.14
 


The fair value of restricted shares is determined based on the closing trading price of the Company’s shares on the grant date. The weighted-average grant-date fair value of shares granted during the three months ended June 30, 2006 and 2005 was $45.75 and $33.90, respectively. The weighted-average grant-date fair value of shares granted during the six months ended June 30, 2006 and 2005 was $41.79 and $33.03, respectively.

As of June 30, 2006, there was $33,980 of unrecognized compensation costs related to non-vested equity-based compensation arrangements that is expected to be recognized over a weighted-average period of 3.5 years. The total fair value of shares vested during the three months ended June 30, 2006 and 2005 was $2,296 and $645, respectively.

 
9

WELLCARE HEALTH PLANS, INC.
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
 
(Unaudited, in thousands, except member and share data)
 
Performance Share Award

Under the 2004 Equity Incentive Plan, the Company granted 240,279 shares to its Chief Executive Officer, the vesting of which and the amount of shares to be awarded is contingent upon achievement of an earnings per share target over three- and five-year performance periods. The fair value of this grant was determined based on the closing price of the Company’s stock on the date of grant and assumes that performance goals will be achieved. If it is determined that such goals will not be met, no compensation cost will be recognized and any recognized compensation cost will be reversed. The grant-date fair value of the shares awarded is $34.95. As of June 30, 2006, there was $6,718 of total unrecognized compensation cost related to the performance share award. This cost is expected to be recognized over a weighted-average period of 4.0 years.

Stock purchase plans

In November 2004, the Company’s board of directors approved the Company’s 2005 Employee Stock Purchase Plan (“ESPP”). The ESPP was subsequently approved by the Company’s shareholders in June 2005. A maximum of 387,714 shares of common stock is reserved for issuance under the plan. The ESPP allows Company associates to purchase common stock of the Company each quarter at a 5% discount from the closing market price on the date of purchase. No compensation cost was incurred for common stock issued under the plan.

 
5. INCOME TAXES

The Company uses the asset and liability method of accounting for income taxes. As of June 30, 2006, net deferred tax assets were approximately $7,902. In assessing the realizability of deferred tax assets, management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies. The Company expects the deferred tax assets to be realized through the generation of future taxable income and the reversal of existing taxable temporary differences.

 
6. CREDIT AGREEMENT

On September 1, 2005, the Company and certain subsidiaries of the Company entered into a First Amendment to the Credit Agreement (the “Amended Credit Agreement”) pursuant to which certain terms of the Credit Agreement, dated as of May 13, 2004 (the “Credit Agreement”) to which the Company and certain of its subsidiaries are parties, were amended.

The credit facilities under the Amended Credit Agreement consist of a senior secured term loan facility in the amount of approximately $156,000 and a revolving credit facility in the amount of $125,000, of which $10,000 is available for short-term borrowings on a swingline basis. Interest is payable quarterly, currently at a rate equal to the sum of a rate based upon the applicable six month LIBOR rate plus a rate equal to 2.50%. The term loan matures in May 2009, and the revolving credit facility will expire in May 2008. The Company is a party to this agreement for the purpose of guaranteeing the indebtedness of its subsidiaries that are parties to the agreement. As of June 30, 2006, the revolving credit facility has not been utilized.

The Amended Credit Agreement contains various restrictive covenants which limit, among other things, the Company’s ability to incur indebtedness and liens and to enter into business combination transactions substantially similar to the covenants contained in the Credit Agreement prior to the effectiveness of the Amended Credit Agreement. The Amended Credit Agreement increased the amount of capital expenditures that the Company is permitted to incur on an annual basis. The Company believes that it is in compliance with all the financial and non-financial covenants under the Amended Credit Agreement as of June 30, 2006.
 
 
7. SUBSEQUENT EVENTS
 
On August 4, 2006, the Company was notified by the Indiana Office of Medicaid Policy and Planning that it was not selected for a new contract to provide managed care benefits to Indiana Medicaid recipients in 2007. The current contract with the state expires on December 31, 2006.  The Company believes that this development does not impact the Company's financial statements as of June 30, 2006.

 

Item 2:  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

The following discussion of our financial condition and results of operations should be read in conjunction with the accompanying unaudited condensed consolidated interim financial statements and the notes to those statements appearing elsewhere in this report and our audited consolidated and combined financial statements and the notes thereto for the year ended December 31, 2005, appearing in the 2005 Form 10-K.

This Quarterly Report on Form 10-Q contains “forward-looking” statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as “may,” “will,” “should,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “predicts,” “potential,” “continues” and similar expressions are forward-looking statements.

Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual future results to differ materially from those projected or contemplated in the forward-looking statements. These risks and uncertainties include, but are not limited to:
 
·  
the potential expiration, cancellation or suspension of our state or federal contracts;
·  
our lack of prior operating history, including lack of experience with network providers and health benefits management, in expansion markets, including Georgia;
·  
our lack of prior operating history in the prescription drug plan (“PDP”) business and potential inability to accurately predict the number of members in our PDP plans, including those who enroll through affirmative choice as well as through auto-assignment and those who disenroll;
·  
our ability to accurately predict and effectively manage health benefits, drug costs and other operating expenses, including our ability to reinsure certain risks related to medical expenses;
·  
the potential for confusion in the marketplace concerning PDP programs resulting from, among other things, the proliferation of health care options facing Medicare beneficiaries and the complexity of the PDP offerings, including the benefit structures;
·  
our ability to accurately estimate incurred but not reported medical costs;
·  
risks associated with future changes in healthcare laws, including repeal or modification of the Medicare Modernization Act of 2003 or any portion thereof;
·  
potential reductions in funding for government healthcare programs, including reductions in funding resulting from the escalating costs of prescription drugs;
·  
risks associated with periodic government reimbursement rate adjustments, the timing of the Centers for Medicare & Medicaid Services (“CMS”) risk-corridor payments to PDP providers and the accounting treatment for the PDP programs;
·  
our ability to develop processes and systems to support our operations and future growth;
·  
regulatory changes and developments, including potential marketing restrictions or sanctions and premium recoupment;
·  
potential fines, penalties or operating restrictions resulting from regulatory audits, examinations, investigations or other inquiries;
·  
risks associated with our acquisition strategy;
·  
risks associated with our efforts to expand into additional states and counties;
·  
risks associated with our substantial debt obligations;
·  
risks associated with the volatility of our common stock; and
·  
risks associated with our rapid growth, including our ability to attract and retain qualified management personnel.

Additional information concerning these and other important risks and uncertainties can be found under the headings “Forward-Looking Statements” and “Risk Factors” in the 2005 Form 10-K, which contain discussions of our business and the various factors that may affect it. We specifically disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.
 

 
Overview
 
We provide managed care services targeted exclusively to government-sponsored healthcare programs, focusing on Medicaid and Medicare. We operate a variety of Medicaid and Medicare plans, including health plans for families, children, the aged, blind and disabled and prescription drug plans, serving over 2.0 million members nationwide as of June 30, 2006.

We serve members who are eligible for Medicare and Medicaid benefits, including individuals who are dually eligible for both Medicare and Medicaid, recipients of the Temporary Assistance to Needy Families programs (“TANF”), Supplemental Security Income programs (“SSI”), State Children’s Health Insurance programs (“S-CHIP”), and the Family Health Plus programs (“FHP”), and Medicare programs, including Medicare Advantage (“MA”) and stand-alone prescription drug plans (“PDP”).

Through our licensed subsidiaries, we operate Medicaid health plans in Florida, New York, Connecticut, Illinois, Indiana and Georgia and Medicare Advantage health plans in Florida, New York, Connecticut, Illinois, Louisiana and Georgia.  Additionally, beginning in January 2006, we began offering PDP products in all 50 states and the District of Columbia.

The following tables summarize our membership by segment and line of business as of June 30, 2006 and 2005. 

   
June 30,
2006
 
June 30,
2005
 
Medicaid
         
TANF
   
856,000
   
589,000
 
S-CHIP
   
85,000
   
80,000
 
SSI
   
59,000
   
60,000
 
FHP
   
27,000
   
20,000
 
     
1,027,000
   
749,000
 
               
Medicare
             
MA
   
83,000
   
59,000
 
PDP
   
901,000
   
-
 
     
984,000
   
59,000
 
               
Total
   
2,011,000
   
808,000
 


We enter into contracts generally with one- to three-year terms with government agencies that administer health benefit programs. We receive premiums from state and federal agencies for the members that are assigned to or have selected us to provide healthcare services under each benefit program. The amount of premiums we receive for each member is fixed, although it varies according to demographics, including the government program, and the member’s geographic location, age and sex. Further, the premiums we receive under each of our government benefit plans are generally determined at the beginning of the contract period. These premiums are subsequently adjusted, up or down, generally at the commencement of each new contract period, although the states also have the ability to adjust the rates during the term of the contract. As a result of these periodic premium rate adjustments, we cannot predict with certainty what our future revenues will be under each of our government contracts.

Our largest expense is the cost of medical benefits that we provide, which is based primarily on our arrangements with healthcare providers. Our profitability depends in part on our ability to predict and effectively manage medical benefits expense relative to the fixed premiums we receive. Our arrangements with providers fall into two broad categories: capitation arrangements, where we pay the providers a fixed fee per member, and fee-for-service and risk-sharing arrangements, where we assume all or part of the risk of the cost of the healthcare provided. Generally, capitation payments represent less than 20% of our total medical benefits expense. Other components of medical benefits expense are variable and require estimation and ongoing cost management.



Estimation of medical benefits expense is our most significant critical accounting estimate. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies.”

We use a variety of techniques to manage our medical benefits expense, including payment methods to providers, referral requirements, quality and disease management programs, reinsurance arrangements and member co-payments and premiums for some of our Medicare plans. National healthcare costs have been increasing at a higher rate than the general inflation rate, however, and relatively small changes in our medical benefits expense relative to premiums that we receive can create significant changes in our financial results. Changes in healthcare laws, regulations and practices, levels of use of healthcare services, competitive pressures, hospital costs, major epidemics, terrorism or bio-terrorism, new medical technologies and other external factors could reduce our ability to manage our medical benefits expense effectively.

One of our primary management tools for measuring profitability is our medical benefits ratio, which is the ratio of our medical benefits expense to the premiums we receive. Changes in the medical benefits ratio from period to period result from, among other things, changes in Medicaid and Medicare funding, changes in the mix of Medicaid and Medicare membership, our ability to manage medical costs and changes in accounting estimates related to incurred but not reported claims. We use medical benefits ratios both to monitor our management of medical benefits expense and to make various business decisions, including what healthcare plans to offer, what geographic areas to enter or exit and the selection of healthcare providers. Although medical benefits ratios play an important role in our business strategy, we may be willing to enter into provider arrangements that might produce a less favorable medical benefits ratio if those arrangements, such as capitation or risk-sharing, would likely lower our exposure to variability in medical costs.

Segments

We have two reportable business segments: Medicaid and Medicare. Medicaid, a state administered program, was enacted in 1965 to make federal matching funds available to all states for the delivery of healthcare benefits to eligible individuals, principally those with incomes below specified levels who meet other state specified requirements. Medicaid is structured to allow each state to establish its own eligibility standards, benefits package, payment rates and program administration under broad federal guidelines. Most states determine threshold Medicaid eligibility by reference to other federal financial assistance programs, including the TANF and SSI programs.

The TANF program provides assistance to low-income families with children and was adopted to replace the Aid to Families with Dependent Children program. SSI is a federal program that provides assistance to low-income aged, blind or disabled individuals. However, states can broaden eligibility criteria.

S-CHIP, developed in 1997, is a federal/state matching program that provides healthcare coverage to children not otherwise covered by Medicaid or other insurance programs. S-CHIP enables a segment of the large uninsured population in the United States to receive healthcare benefits. States have the option of administering S-CHIP through their Medicaid programs.

FHP is a New York State program that provides health insurance for certain adults and their families between the ages of 19 and 64 who do not have health insurance on their own, but have income too high to qualify for Medicaid.

Medicare is a federal program that provides eligible persons age 65 and over and some disabled persons a variety of hospital, medical insurance and prescription drug benefits. Most individuals eligible for Medicare are entitled to receive inpatient hospital care without the payment of any premium, but are required to pay a premium to the federal government, which is adjusted annually, to be eligible for physician care and other services.


Under the MA program, managed care plans can contract with the Centers for Medicare & Medicaid Services (“CMS”) to provide health insurance coverage in exchange for a fixed monthly payment per member that varies based on the geographic areas in which the members reside. The fixed monthly payment per member is subject to periodic adjustments determined by CMS based upon a number of factors, including retroactive changes in members’ status such as Medicaid eligibility, and risk measures based on demographic factors such as age, gender, county of residence and health status. The weighting of the risk measures in the determination of the amount of the periodic adjustments to the fixed monthly payments is being phased in over time. These measures will have their full impact on the calculation of those adjustments by 2007. Individuals who elect to participate in the MA program are relieved of the obligation to pay some or all of the deductible or coinsurance amounts required under the traditional Medicare program, but are generally required to use the services provided by the MA plan’s network providers exclusively and may be required to pay a premium to the federal Medicare program unless the MA plan chooses to pay the premium as part of its benefit package.

As part of the Medicare reform legislation known as the Medicare Prescription Drug, Improvement and Modernization Act of 2003, or MMA, beginning in January 2006, every Medicare recipient was provided the opportunity to select a prescription drug plan through Medicare Part D, largely funded by the federal government. The Medicare Part D benefit is available to Medicare managed care enrollees as well as Medicare fee-for-service enrollees. Medicare managed care organizations are required to offer a Part D drug benefit plan, called a MA-PD plan, in every region in which they operate.

In addition, Medicare fee-for-service beneficiaries are able to purchase a stand-alone prescription drug plan, called a PDP plan, from a list of CMS-approved PDP plans available in their region. CMS has created 34 PDP regions nationwide. In September 2005, CMS awarded us a contract to offer stand-alone PDP plans in all 34 CMS regions. In addition, we are eligible to receive auto-assignments of Medicare dual-eligible beneficiaries into our PDP plans in 33 of the 34 regions, with Arizona being the sole exception.
 
As of January 1, 2006, we began offering PDP plans nationwide in each of the 34 PDP CMS regions. As of June 30, 2006, we had approximately 901,000 PDP members. However, our ability to accurately estimate our PDP membership is currently constrained, in part, due to challenges with regard to the timing and administration of enrollments and disenrollments by CMS. In addition, we have several large and well-known competitors in the Medicare marketplace who have greater brand recognition than we do and who are spending considerably more on marketing than we are. This competition could cause our PDP members to select another plan.
 
Further, we expect seasonality and fluctuations in our PDP earnings on a quarterly basis resulting from the design of our benefits and the interaction of various product features, such as deductibles, co-payments, the coverage gap, catastrophic coverage, risk corridors and reinsurance arrangements, all of which will impact our PDP earnings. We estimate that our PDP medical costs will be higher in the first half of the year than in the second half of the year. As a result, our net income margins are lower in the first half of the year and are expected to increase in the second half of the year.
 
We have purchased a one-year, nonrenewable, aggregate reinsurance policy to mitigate the risks associated with our new PDP product by complementing the risk corridor protection and catastrophic coverage provided by CMS under the Medicare Part D program. The terms of this aggregate reinsurance policy result in higher recoveries in periods of higher medical benefits ratios and lower or no recoveries in periods of lower medical benefits ratios. The recoveries and net reinsurance impact under this aggregate reinsurance policy are cumulative over the one-year term of the policy. The medical benefits ratio of our PDP business in the first quarter of 2006 resulted in a net reinsurance recovery of $10.0 million which favorably impacted our first quarter gross profit on our Medicare segment. The results of our PDP business in the second quarter of 2006 were favorably impacted by increased membership coupled with favorable medical utilization and cost trends, resulting in lower medical benefits ratios. As a result, the gross profit on our Medicare segment in the second quarter was unfavorably impacted by a reinsurance expense of $11.0 million for the three-month period ended June 30, 2006, resulting in a net reinsurance expense of $1.0 million for the six-month period ended June 30, 2006.  Based on the performance of our PDP business in the first half of 2006 and assuming it performs in line with our current expectations for the second half of the year, we expect to incur an additional net reinsurance expense in the second half of 2006. However, in the event our PDP business does not perform according to our expectations, the net reinsurance impact could be different. Should we determine that a similar reinsurance arrangement would be warranted in future years, there can be no assurance that we will be able to obtain such reinsurance coverage.
 
 
Expansion Initiatives
 
We continually identify markets for potential acquisitions or expansion that would increase our membership and broaden our geographic presence. These potential acquisitions or expansion efforts are at various stages of internal consideration, and we may enter into letters of intent, transactions or other arrangements supporting our growth strategy at any time. However, we cannot predict when or whether such transactions or other arrangements will actually occur, and we may not be successful in completing potential acquisitions. In June 2006, we acquired a shell life and health insurance company to facilitate possible future product expansion initiatives, such as Medicare private fee-for-service.
 
On August 4, 2006, we were notified by the Indiana Office of Medicaid Policy and Planning that we were not selected for a new contract to provide managed care benefits to Indiana Medicaid recipients in 2007. The current contract with the state expires on December 31, 2006.  We believe that this development will have no material impact on our full-year earnings for 2006.
 
Critical Accounting Policies

In the ordinary course of business, we make a number of estimates and assumptions relating to the reporting of our results of operations and financial condition in conformity with accounting principles generally accepted in the United States of America. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe that the accounting policies discussed below are those that are most important to the presentation of our financial condition and results and require management’s most difficult, subjective and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

Revenue recognition. We generate revenues primarily from premiums we receive from agencies of the federal government and the states in which we operate to provide healthcare benefits to our members. We receive a fixed premium per member per month to provide healthcare benefits to our members pursuant to our contracts in each of our markets. We generally receive premiums in advance of providing services, and recognize premium revenue during the period in which we are obligated to provide services to our members. Premiums collected in advance of the period in which we are obligated to provide services are deferred and reported as unearned premiums. Any amounts that have not been received remain on the balance sheet classified as premiums receivable. We also generate revenues from investments.

We experience adjustments to our revenues based on member retroactivity. These retroactivity adjustments reflect changes in the number and eligibility status of enrollees subsequent to when revenue is billed. We estimate the amount of outstanding retroactivity each period and adjust premium revenue accordingly. The estimates of retroactivity adjustments are based on historical trends, premiums billed, the volume of member and contract renewal activity and other information. We refine our estimates and methodologies based upon actual retroactivity experienced. Retroactivity adjustments have not been significant.

Estimating medical benefits expense and medical benefits payable. The cost of medical benefits is recognized in the period in which services are provided and includes an estimate of the cost of medical benefits that have been incurred but not yet reported. We contract with various healthcare providers for the provision of certain medical care services to our members and generally compensate those providers on a capitated basis or pursuant to fee-for-service and certain risk-sharing arrangements. Capitation represents fixed payments on a per member per month basis to participating physicians and other medical specialists as compensation for providing comprehensive healthcare services.

Medical benefits expense has two main components: direct medical expenses and medically-related administrative costs. Direct medical expenses include amounts paid to hospitals, physicians and providers of ancillary services, such as laboratory and pharmacy. Medically-related administrative costs include items such as case and disease management, utilization review services, quality assurance and on-call nurses. Medical benefits expense is also affected by recoveries from reinsurance contracts and claim audits from internal and external parties.

Medical benefits payable consists primarily of benefit reserves established for reported and unreported claims, which are unpaid as of the balance sheet date, and contractual liabilities under risk-sharing arrangements, determined through an estimation process utilizing Company-specific, industry-wide and general economic information and data.

We have used a consistent methodology for estimating our medical benefits expense and medical benefits payable. Our policy is to record management’s best estimate of medical benefits payable, which considers the effect of reinsurance recoveries in setting the appropriate level of reserves. Monthly, we estimate ultimate benefits payable based upon historical experience and other available information as well as assumptions about emerging trends, which vary by business segment. The process for preparing the estimate utilizes standard actuarial methodologies based on historical data. These standard actuarial methodologies include, among other factors, contractual requirements, historic utilization trends, the interval between the date services are rendered and the date claims are paid, denied claims activity, disputed claims activity, benefits changes, expected health care cost inflation, seasonality patterns and changes in membership. In developing the estimate, we apply different estimation methods depending on the month for which incurred claims are being estimated. For the more recent months, which constitute the majority of the amount of the medical benefits payable, we estimate our claims incurred by applying observed trend factors to the per member per month, or PMPM, costs for prior months, which costs have been estimated using completion factors, in order to estimate the PMPMs for the most recent months. We validate our estimates of the most recent PMPMs by comparing the most recent months’ utilization levels to the utilization levels in older months, actuarial techniques that incorporate a historical analysis of claim payments, including trends in cost of care provided and timeliness of submission and processing of claims.


Also included in medical benefits payable are estimates for provider settlements due to clarification of contract terms, out-of-network reimbursement, claims payment differences and recoveries from reinsurance contracts, as well as amounts due to contracted providers under risk-sharing arrangements.

Many aspects of the managed care business are not predictable with consistency. These aspects include the incidences of illness or disease (such as cardiac heart failure cases, cases of upper respiratory illness, the length and severity of the flu season, diabetes, the number of full-term versus premature births and the number of neonatal intensive care babies). Therefore, we must rely upon our historical experience, as continually monitored, to reflect the ever-changing mix, needs and growth of our membership in our trend assumptions. Among the factors considered by management are changes in the level of benefits provided to members, seasonal variations in utilization, identified industry trends and changes in provider reimbursement arrangements, including changes in the percentage of reimbursements made on a capitation as opposed to a fee-for-service basis. These considerations are aggregated in making assumptions regarding trends in medical benefits expense. Other external factors such as government-mandated benefits or other regulatory changes, catastrophes and epidemics may impact medical cost trends. Other internal factors such as system conversions and claims processing interruptions may impact our ability to predict accurately estimates of historical completion factors or medical cost trends. Medical cost trends potentially are more volatile than other segments of the economy. Management is required to use considerable judgment in the selection of medical benefits expense trends and other actuarial model inputs.

We record reserves for estimated referral claims related to healthcare providers under contract with us who are financially troubled or insolvent and who may not be able to honor their obligations for the costs of medical services provided by other providers. In these instances, we may be required to honor these obligations for legal or business reasons. Based on our current assessment of providers under contract with us, such losses have not been and are not expected to be significant.

Changes in estimates of medical benefits payable are primarily the result of obtaining more complete claims information that directly correlates with the claims and provider reimbursement trends. Volatility in members’ needs for medical services, provider claims submissions and our payment processes result in identifiable patterns emerging several months after the causes of deviations from assumed trends occur. Since our estimates are based upon PMPM claims experience, changes cannot typically be explained by any single factor, but are the result of a number of interrelated variables, all influencing the resulting experienced medical cost trend. Deviations, whether positive or negative, between actual experience and estimates used to establish the liability are recorded in the period known.

Goodwill and intangible assets. We obtained goodwill and intangible assets as a result of the acquisitions of the WellCare group of companies in 2002 and Harmony Health Systems in June 2004. Goodwill represents the excess of the cost over the fair market value of net assets acquired. Intangible assets include provider networks, membership contracts, trademarks, noncompete agreements, government contracts, licenses and permits. Our intangible assets are amortized over their estimated useful lives ranging from one to 26 years.

We evaluate whether events or circumstances have occurred that may affect the estimated useful life or the recoverability of the remaining balance of goodwill and other identifiable intangible assets. We must make assumptions and estimates, such as the discount factor, in determining the estimated fair values. While we believe these assumptions and estimates are appropriate, other assumptions and estimates could be applied and might produce significantly different results.
 
We review goodwill and intangible assets for impairment at least annually, or more frequently if events or changes in circumstances occur that may affect the estimated useful life or the recoverability of the remaining balance of goodwill or intangible assets. Events or changes in circumstances would include significant changes in membership, state funding, medical contracts and provider networks. We have selected the third quarter of each fiscal year for our annual impairment test, which generally coincides with the finalization of state and federal contract negotiations and our initial budgeting process.


Results of Operations

The following table sets forth the condensed consolidated statements of income data, expressed as a percentage of total revenues for each period indicated. The historical results are not necessarily indicative of results to be expected for any future period.

   
Three Months
Ended June 30,
 
Six Months
Ended June 30,
 
   
2006
 
2005
 
2006
 
2005
 
Statement of Operations Data:
                 
Revenues
                 
Premium
   
98.8
%
 
99.2
%
 
98.8
%
 
99.3
%
Investment and other income
   
1.2
%
 
0.8
%
 
1.2
%
 
0.7
%
Total revenues
   
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%
Expenses
                         
Medical benefits
   
82.7
%
 
80.6
%
 
82.4
%
 
81.5
%
Selling, general and administrative
   
12.3
%
 
13.0
%
 
12.7
%
 
12.6
%
Depreciation and amortization
   
0.4
%
 
0.5
%
 
0.4
%
 
0.5
%
Interest
   
0.4
%
 
0.8
%
 
0.5
%
 
0.8
%
Total expenses
   
95.8
%
 
94.9
%
 
96.0
%
 
95.4
%
Income before income taxes
   
4.2
%
 
5.1
%
 
4.0
%
 
4.6
%
Income tax expense
   
1.7
%
 
2.0
%
 
1.6
%
 
1.8
%
Net Income
   
2.5
%
 
3.1
%
 
2.4
%
 
2.8
%


One of our primary management tools for measuring profitability is our medical benefits ratio, the ratio of our medical benefits expense to the premiums we receive. Changes in the medical benefits ratio from period to period result from, among other things, changes in Medicaid and Medicare funding, changes in the mix of Medicaid and Medicare membership, our ability to manage medical costs and changes in accounting estimates related to incurred but not reported claims. We use medical benefits ratios both to monitor our management of medical benefits expense and to make various business decisions, including what healthcare plans to offer, what geographic areas to enter or exit and the selection of healthcare providers. Although medical benefits ratios play an important role in our business strategy, we may be willing to enter into provider arrangements that might produce a less favorable medical benefits ratio if those arrangements, such as capitation or risk-sharing, would likely lower our exposure to variability in medical costs.

Three and Six Month Periods Ended June 30, 2006 Compared to the Three and Six Month Periods Ended June 30, 2005

Premium revenue. Premium revenues for the three months ended June 30, 2006 increased $392.5 million, or 87.2%, to $842.7 million from $450.2 million for the same period last year. For the six months ended June 30, 2006, premium revenues increased $698.8 million, or 80.7%, to $1.6 billion from $866.1 million for the same period last year. The increase is primarily attributable to the addition of members from membership growth in both our Medicaid and Medicare segments. The Medicaid segment increase is principally in Georgia and the Medicare segment increase is principally in PDP. Total membership grew by approximately 1,203,000 members, or 148.9%, from 808,000 at June 30, 2005 to 2,011,000 at June 30, 2006.


 Our Medicaid segment includes Medicaid programs and other state-sponsored healthcare programs. The Medicaid segment premium revenue for the three months ended June 30, 2006 increased $57.4 million, or 17.4%, to $388.0 million from $330.5 million for the same period last year. For the six months ended June 30, 2006, Medicaid segment premium revenue increased $101.7 million, or 15.9%, to $741.4 million from $639.7 million for the same period last year. The increase in Medicaid segment revenue is due to growth in membership, principally in Georgia, coupled with increases in premium rates in certain markets. Aggregate membership in our Medicaid segment grew by 278,000 members, or 37.1%, from 749,000 at June 30, 2005 to 1,027,000 at June 30, 2006.


   
Medicaid Revenues and Membership
 
   
Three Months Ended June 30,
 
Six Months Ended June 30,
 
   
2006
 
2005
 
2006
 
2005
 
Revenues
 
$
388.0
 
$
330.5
 
$
741.4
 
$
639.7
 
% of Total Premium Revenues
   
46.0
%
 
73.4
%
 
47.4
%
 
73.9
%
                           
Membership
   
1,027,000
   
749,000
   
1,027,000
   
749,000
 
% of Total Membership
   
51.1
%
 
92.7
%
 
51.1
%
 
92.7
%


Medicare segment premium revenue for the three months ended June 30, 2006 increased $335.1 million, or 280.0%, to $454.7 million from $119.7 million for the same period last year. For the six months ended June 30, 2006, Medicare segment premium revenue increased $597.1 million, or 263.9%, to $823.5 million from $226.3 million for the same period last year. Growth in premium revenue within the Medicare segment was primarily due to PDP membership growth of 901,000 members and premium increases associated with the demographic mix of our Medicare Advantage membership growth. Membership within the Medicare segment grew by 925,000 members, or 1,567%, from 59,000 at June 30, 2005 to 984,000 at June 30, 2006, principally due to the new PDP product.

   
Medicare Revenues and Membership
 
   
Three Months Ended June 30,
 
Six Months Ended June 30,
 
   
2006
 
2005
 
2006
 
2005
 
Revenues
 
$
454.7
 
$
119.7
 
$
823.5
 
$
226.3
 
% of Total Premium Revenues
   
54.0
%
 
26.6
%
 
52.6
%
 
26.1
%
                           
Membership
   
984,000
   
59,000
   
984,000
   
59,000
 
% of Total Membership
   
48.9
%
 
7.3
%
 
48.9
%
 
7.3
%


Investment income. Investment income for the three months ended June 30, 2006 increased $6.7 million, or 191.1%, to $10.2 million from $3.5 million for the same period last year. For the six months ended June 30, 2006, investment income increased $11.8 million, or 181.7%, to $18.3 million from $6.5 million for the same period last year. The increase was due primarily to the investment of proceeds from our public offerings, excess cash generated by operations and a higher interest rate environment.

Medical benefits expense. Medical benefits expense for the three months ended June 30, 2006 increased $339.2 million, or 92.7%, to $705.0 million from $365.8 million for the same period last year. For the six months ended June 30, 2006, medical benefits expense increased $593.3 million, or 83.5%, to $1.3 billion from $710.7 million for the same period last year. The increase in medical benefits expense was due to growth in membership, principally in PDP and Georgia. The medical benefits ratio, which represents our medical benefits expense as a percentage of premium revenue, for the three months ended June 30, 2006 was 83.7% compared to 81.3% for the same period last year. For the six months ended June 30, 2006, the medical benefits ratio was 83.3% compared to 82.1% for the same period last year. The medical benefits ratio increased primarily as a result of the seasonally higher medical benefits expense ratios associated with our PDP business.



The Medicaid segment medical benefits expense for the three months ended June 30, 2006 increased $40.8 million, or 15.1%, to $310.3 million from $269.5 million for the same period last year. The increase in Medicaid medical benefits expense was primarily due to growth in membership, principally in Georgia, accounting for $40.2 million of the increase when comparing the three-month periods.  For the six months ended June 30, 2006, Medicaid medical benefits expense increased $62.0 million, or 11.7%, to $589.5 million from $527.5 million for the same period last year. Membership growth accounted for $63.0 million of the increase when comparing the six-month periods, partially off-set by the favorable trends in some of our other markets. The Medicaid medical benefits ratio for the three months ended June 30, 2006 was 80.0% compared to 81.5% for the same period last year. For the six months ended June 30, 2006, the Medicaid medical benefits ratio was 79.5% compared to 82.5% for the same period last year. This decline resulted from premium rate increases, changes in the healthcare utilization pattern of our members and the demographic mix of our members.


   
Medicaid Medical Benefits Expense
 
   
Three Months Ended June 30,
 
Six Months Ended June 30,
 
   
2006
 
2005
 
2006
 
2005
 
Medical Benefits
 
$
310.3
 
$
269.5
 
$
589.5
 
$
527.5
 
MBR
   
80.0
%
 
81.5
%
 
79.5
%
 
82.5
%


Medicare segment medical benefits expense for the three months ended June 30, 2006 increased $298.4 million, or 309.9%, to $394.7 million from $96.3 million for the same period last year. The increase was primarily due to the growth in membership, principally in PDP, which accounted for $265.0 million of the increase in the quarter. Increased healthcare costs and changes in membership mix accounted for $33.4 million of the remaining quarterly increase. For the six months ended June 30, 2006, Medicare medical benefits expense increased $531.4 million, or 290.0%, to $714.6 million from $183.2 million for the same period last year. Membership growth accounted for $488.4 million of the increase in the six-month period, while increased healthcare costs and changes in membership mix accounted for the remaining $43.0 million six-month increase. The Medicare medical benefits ratio for the three months ended June 30, 2006 was 86.8% compared to 80.5% for the same period last year. For the six months ended June 30, 2006, the Medicare medical benefits ratio was 86.8% compared to 81.0% for the same period last year. The medical benefits ratio increased primarily as a result of the seasonally higher medical benefits expense ratios associated with our PDP business.

   
Medicare Medical Benefits Expense
 
   
Three Months Ended June 30,
 
Six Months Ended June 30,
 
   
2006
 
2005
 
2006
 
2005
 
Medical Benefits
 
$
394.7
 
$
96.3
 
$
714.6
 
$
183.2
 
MBR
   
86.8
%
 
80.5
%
 
86.8
%
 
81.0
%


Selling, general and administrative expense. Selling, general and administrative (“SG&A”) expense for the three months ended June 30, 2006 increased $45.5 million, or 77.0%, to $104.6 million from $59.1 million for the same period last year. For the six months ended June 30, 2006, SG&A expense increased $91.5 million, or 82.9%, to $201.8 million from $110.3 million for the same period last year. Our SG&A expense to revenue ratio was 12.3% for the three months ended June 30, 2006 compared to 13.0% for the same period last year. For the six months ended June 30, 2006, our SG&A expense to revenue ratio was 12.7% compared to 12.6% for the same period last year. The increase in SG&A expense was primarily due to increased spending necessary to support and sustain our membership growth.

   
Three Months Ended June 30,
 
Six Months Ended June 30,
 
   
2006
 
2005
 
% Change
 
2006
 
2005
 
% Change
 
Selling, general and administrative expenses (SG&A)
                         
SG&A
 
$
104.6
 
$
59.1
   
77.0%
 
$
201.8
 
$
110.3
   
82.9
%
SG&A expense to total revenue ratio
   
12.3
%
 
13.0
%
       
12.7
%
 
12.6
%
     


Interest expense. Interest expense was $3.7 million and $3.6 million for the three months ended June 30, 2006 and 2005, respectively, and $7.1 million and $6.8 million for the six months ended June 30, 2006 and 2005, respectively. The increase primarily relates to the higher interest rate environment.
 
19

 
Income tax expense. Income tax expense for the three months ended June 30, 2006 was $14.2 million with an effective tax rate of 39.0% as compared to $9.0 million for the same period last year with an effective tax rate of 38.9%. Income tax expense for the six months ended June 30, 2006 was $25.0 million with an effective tax rate of 39.1% as compared to $15.8 million for the same six-month period last year with an effective tax rate of 39.0%.

   
Three Months Ended June 30,
 
Six Months Ended June 30,
 
   
2006
 
2005
 
% Change
 
2006
 
2005
 
% Change
 
Income Tax Expense
                         
Income tax expense
 
$
14.2
 
$
9.0
   
57.4%
 
$
25.0
 
$
15.8
   
57.7
%
Effective tax rate
   
39.0
%
 
38.9
%
       
39.1
%
 
39.0
%
     

Net income. Net income for the three months ended June 30, 2006 was $22.2 million compared to $14.2 million for the same period last year, representing an increase of 56.7%. For the six months ended June 30, 2006, net income was $38.9 million compared to $24.8 million for the same period last year, representing an increase of 57.1%.
 

   
Three Months Ended June 30,
 
Six Months Ended June 30,
 
   
2006
 
2005
 
% Change
 
2006
 
2005
 
% Change
 
                           
Net Income
 
$
22.2
 
$
14.2
   
56.7%
 
$
38.9
 
$
24.8
   
57.1
%
Net Income Per Diluted Share
 
$
0.55
 
$
0.36
   
52.8%
 
$
0.97
 
$
0.64
   
51.6
%
 
Liquidity and Capital Resources

We manage our cash and investments in a manner that allows us to meet our short term, long term and regulatory requirements. We continuously monitor and forecast our capital resources to ensure that we maintain the financial flexibility we need to take advantage of viable business opportunities.

Our regulated subsidiaries are financed principally through internally generated funds. We generate cash mainly from premium revenue, and we generally receive premium revenue in advance of payment of claims for related healthcare services. Our primary use of cash is the payment of expenses related to medical benefits and administrative costs. Our investment policies are designed primarily to provide liquidity and preserve capital. The states in which we operate prescribe the types of instruments in which our regulated subsidiaries may invest their funds. As of June 30, 2006 and 2005, a significant portion of our cash was invested in certificates of deposit and a portfolio of highly liquid money market securities with a weighted average maturity of 86 days and 54 days, respectively. The average portfolio yield for the three-month periods ended June 30, 2006 and 2005, was approximately 3.87% and 2.16%, respectively.

Our non-regulated businesses also generate positive cash flows that are used for corporate purposes. At June 30, 2006, free cash in our non-regulated businesses was $149.0 million. We generally invest cash generated from our non-regulated entities in certificates of deposit and government municipal bonds. The factors that we consider in making these investment decisions include term to maturity, rate of return and ratings for municipal bonds.
 
We expect our future funding for working capital needs, capital expenditures, long-term debt repayments, and other financing activities will continue to be provided from these resources. From time to time, we may need to raise additional capital or draw on our revolving credit facility to fund planned geographic and product expansion or acquire healthcare businesses. As of June 30, 2006, we had not utilized our revolving credit facility.

Each of our existing and anticipated sources of cash are impacted by operational and financial risks that influence the overall amount of cash generated and the capital available to us. For a further discussion of risks that can impact our liquidity, see the risk factor discussion included in the 2005 Form 10-K.

 
 
As we generally receive premiums in advance of payments of claims for healthcare services, we maintain balances of cash and cash equivalents pending payment of claims. As of June 30, 2006 and 2005, cash and cash equivalents were $834.2 million and $253.5 million, respectively. We also had short-term investments of $178.8 million and $178.1 million at June 30, 2006 and 2005, respectively.
 
Overview of Cash Flow Activities

For the six-month periods ended June 30, 2006 and 2005 our cash flows are summarized as follows (in thousands):

   
Six Months Ended June 30,
 
   
2006
 
2005
 
Net cash provided by (used in) operations
 
$
279,783
 
$
(20,770
)
Net cash used in investing activities
   
(118,344
)
 
(123,334
)
Net cash provided by (used in) financing activities
   
250,954
   
(28
)

Cash From Operations: As we generally receive premiums in advance of payments of claims for healthcare services, we maintain balances of cash and cash equivalents pending payment of claims. During the six-month period ended June 30, 2006, cash provided from operations consisted primarily of $38.9 million of net income from operations, an increase in medical benefits payable of $180.7 million, an increase in accounts payable and accrued expenses of $69.3 million, an increase of $149.3 million in unearned premiums principally due to the commencement of our PDP program and $23.7 million increase in taxes payable.

Cash From Investing Activities: During the six-month period ended June 30, 2006, investing activities consisted primarily of the investment of excess cash generated by operations totaling approximately $95.9 million in various short term investment instruments. An additional $21.5 million was invested in capitalized assets, which included expansion costs related to our Tampa facility, and investments in technology needed to sustain our membership growth.

Cash From Financing Activities: We have a senior secured term loan facility of approximately $156.3 million and a revolving credit facility in the amount of $125.0 million, of which $10.0 million is available for short-term borrowings on a swing-line basis. The term loan matures in May 2009, and the revolving credit facility will expire in May 2008. As of June 30, 2006, the revolving credit facility had not been utilized. As of June 30, 2006, our outstanding term loan interest rate was 7.625%.

Our senior debt is rated B+ by Standard & Poor’s and Ba3 by Moody’s as of June 30, 2006. These credit rating agencies have indicated that, based on our performance, they will be reviewing our credit rating again in 2006.

In February 2006, we filed a shelf registration statement for common stock with the Securities and Exchange Commission (the “SEC”), which became automatically effective upon filing. In March 2006, we completed a public offering of 4,850,000 shares of common stock, of which 500,000 were sold by us and 4,350,000 shares were sold by certain selling stockholders at an offering price of $39.56. We received approximately $18.8 million in net proceeds after deducting underwriting discounts, commissions and other expenses. Subsequently in April 2006, the over-allotment option of 727,500 shares was fully exercised, of which 75,000 were sold by us and 652,000 were sold by selling stockholders. We received net proceeds of approximately $2.8 million from this over-allotment transaction. We did not receive any proceeds from the sale of shares of common stock by the selling stockholders in either transaction.
 
Also included in financing activities are funds held for the benefit of others, which totaled approximately $224.7 million as of June 30, 2006. These PDP member subsidies represent pass-through payments from government partners and are not accounted for in the Company’s results of operations since they represent pass-through payments from our government partners to fund deductibles, co-payments and other member benefits for certain of our members.


 
Off-Balance Sheet Arrangements

As of June 30, 2006, we did not have any off-balance sheet arrangements that are required to be disclosed under Item 303(a)(4) of Regulation S-K.


Item 3:  Quantitative and Qualitative Disclosures About Market Risk.

As of June 30, 2006, we had cash and cash equivalents of $834.2 million, investments classified as current assets of $178.8 million, and restricted investments on deposit for licensure of $48.5 million. The short-term investments classified as current assets consist of highly liquid securities with maturities between three and twelve months and longer term bonds with floating interest rates that are considered available for sale. Long-term restricted assets consist of cash and cash equivalents deposited or pledged to state agencies in accordance with state rules and regulations. These restricted assets are classified as long-term regardless of the contractual maturity date due to the long-term nature of the states’ requirements. The investments classified as long-term are subject to interest rate risk and will decrease in value if market rates increase. Because of their short-term pricing nature, however, we would not expect the value of these investments to decline significantly as a result of a sudden change in market interest rates. Assuming a hypothetical and immediate 1% increase in market interest rates as of June 30, 2006, the fair value of our fixed income investments would decrease by less than $1.5 million. Similarly, a 1% decrease in market interest rates as of June 30, 2006 would result in an increase of the fair value of our investments of less than $2.0 million. 


Item 4:  Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our management carried out an evaluation required by Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), under the supervision and with the participation of our President and Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15 under the Exchange Act (“Disclosure Controls”). Based on the evaluation, our CEO and CFO concluded that as of June 30, 2006, our Disclosure Controls are effective in timely alerting them to material information required to be included in our reports filed with the SEC.

Changes in Internal Controls

There has not been any change in our internal controls over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) identified in connection with the evaluation required by Rule 13a-15(b) under the Exchange Act of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(c) under the Exchange Act) as of June 30, 2006 that has materially affected, or is reasonably likely to materially affect, those controls.


 
Limitations on the Effectiveness of Controls

Our management, including our CEO and CFO, does not expect that our Disclosure Controls and internal controls will prevent all errors and fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls.

The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected.




 
Part II - OTHER INFORMATION


Item 1:  Legal Proceedings.

We are involved in legal actions in the normal course of business, some of which seek monetary damages, including claims for punitive damages, which, if payable, are not covered by insurance. These actions, when finally concluded and determined, will not, in our opinion, have a material adverse effect on our financial position, results of operations or cash flows. We believe that we have obtained adequate insurance or rights to indemnification or, where appropriate, have established adequate reserves in connection with these legal proceedings.
 
Item 1A:    Risk Factors.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2005 Form 10-K which could materially affect our business, financial condition or future results. There have been no material changes in our risk factors from those disclosed in our 2005 Form 10-K.
 
Item 2:      Unregistered Sales of Equity Securities and Use of Proceeds.
 
In connection with our initial public offering of our common stock, the SEC declared our Registration Statement on Form S-1 (No. 333-112829), filed under the Securities Act of 1933, effective on June 29, 2004.

Upon the completion of our initial public offering, we invested the net proceeds from the offering in short-term, interest-bearing, investment-grade securities. As of June 30, 2006, we have not used any of the proceeds from the offering.
 
Item 4:      Submission of Matters to a Vote of Security Holders.
 
Our Annual Meeting of Stockholders was held on June 7, 2006.  We solicited proxies for the meeting  pursuant to Regulation 14 under the Exchange Act; there was no solicitation in opposition to management’s nominees as listed in the proxy statements and all such nominees were elected.  The continuing directors whose terms expire in 2007 are Alif Hourani, Neal Moszkowski and Jane Swift.  The continuing directors whose terms expire in 2008 are Todd Farha, Kevin Hickey and Regina Herzlinger.  At the meeting, the matters listed below were submitted to a vote of our stockholders. 

 
Proposal One:
The election of three directors to serve as Class II Directors through 2009. The vote with respect to each nominee was as follows:
     
(a)
34,900,355 votes were cast for the election of Andrew Agwunobi, M.D as a director; 904,320 votes were withheld.
 
(b)
34,892,974 votes were cast for the election of Ruben Jose King-Shaw, Jr. as a director; 912,601 votes were withheld.
 
(c)
34,886,346 votes were cast for the election of Christian P. Michalik as a director; 918,329 votes were withheld.
 
     
 
Proposal Two:
Ratification of independent registered public accounting firm for 2006. The vote with respect to Deloitte & Touche LLP was as follows:
     
(a)
35,349,009 votes were cast for the ratification of Deloitte & Touche LLP as our independent registered accounting firm, 417,849 against, and 37,816 abstentions.
 


24

 
Item 6: Exhibits.
 
The following exhibits are included herein:

Exhibit
Number
 
 
Description
3.1
 
Registrant’s Amended and Restated Certificate of Incorporation, incorporated by reference to an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.
3.2
 
Registrant’s Amended and Restated Bylaws, incorporated by reference to an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.
4.1
 
Specimen common stock certificate of Registrant, incorporated by reference to an exhibit to Amendment No. 3 to the Registration Statement on Form S-1 filed by the Registrant on June 29, 2004 (No. 333-112829).
10.1
 
Medicaid Managed Care and Family Health Plus Model Contract between the City of New York Department of Health and Mental Hygiene and WellCare of New York, Inc., incorporated by reference to an exhibit to the Registrant’s Current Report on Form 8-K filed on April 5, 2006.
10.2
 
Purchase of Service Contract number 093-HUS-WCC-2, between the State of Connecticut Department of Social Services and WellCare of Connecticut, Inc., incorporated by reference to an exhibit to the Registrant’s Current Report on Form 8-K filed on June 6, 2006.
10.3
 
Amendment No. 15 to Purchase of Service Contract number 093-MED-WCC-1, between the State of Connecticut Department of Social Services and WellCare of Connecticut, Inc., incorporated by reference to an exhibit to the Registrant’s Current Report on Form 8-K filed on June 6, 2006.
10.4
 
Offer Letter to Heath Schiesser, dated June 7, 2006, incorporated by reference to an exhibit to the Registrant’s Current Report on Form 8-K filed on June 6, 2006.
10.5
 
Amendment No. 11 to AHCA contract between the State of Florida, Agency for Health Care Administration and HealthEase of Florida, Inc.
10.6
 
Amendment No. 12 to AHCA contract between the State of Florida, Agency for Health Care Administration and WellCare HMO, Inc. d/b/a Staywell Health Plan of Florida.
 
 
 
 
 
* Filed herewith




SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized in Tampa, Florida on August 4, 2006.

 
WELLCARE HEALTH PLANS, INC.
     
 
By:
/ s / Paul L. Behrens                                  
   
Paul L. Behrens, Chief Financial Officer
   
(Principal Financial and Accounting Officer and duly authorized officer)
 

 



EXHIBIT INDEX

The following exhibits are included herein:


Exhibit
Number
 
 
Description
3.1
 
Registrant’s Amended and Restated Certificate of Incorporation, incorporated by reference to an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.
3.2
 
Registrant’s Amended and Restated Bylaws, incorporated by reference to an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.
4.1
 
Specimen common stock certificate of Registrant, incorporated by reference to an exhibit to Amendment No. 3 to the Registration Statement on Form S-1 filed by the Registrant on June 29, 2004 (No. 333-112829).
10.1
 
Medicaid Managed Care and Family Health Plus Model Contract between the City of New York Department of Health and Mental Hygiene and WellCare of New York, Inc., incorporated by reference to an exhibit to the Registrant’s Current Report on Form 8-K filed on April 5, 2006.
10.2
 
Purchase of Service Contract number 093-HUS-WCC-2, between the State of Connecticut Department of Social Services and WellCare of Connecticut, Inc., incorporated by reference to an exhibit to the Registrant’s Current Report on Form 8-K filed on June 6, 2006.
10.3
 
Amendment No. 15 to Purchase of Service Contract number 093-MED-WCC-1, between the State of Connecticut Department of Social Services and WellCare of Connecticut, Inc., incorporated by reference to an exhibit to the Registrant’s Current Report on Form 8-K filed on June 6, 2006.
10.4
 
Offer Letter to Heath Schiesser, dated June 7, 2006, incorporated by reference to an exhibit to the Registrant’s Current Report on Form 8-K filed on June 6, 2006.
10.5
 
Amendment No. 11 to AHCA contract between the State of Florida, Agency for Health Care Administration and HealthEase of Florida, Inc.
10.6
 
Amendment No. 12 to AHCA contract between the State of Florida, Agency for Health Care Administration and WellCare HMO, Inc. d/b/a Staywell Health Plan of Florida.
 
 
 
 
 
* Filed herewith